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Objectives: The aim of this study was to evaluate occlusion rates of
great saphenous veins (GSV) with a diameter between 5-10 mm that
received a pre-treatment size reduction via perivenous tumescent application
(TA) followed by catheter-directed foam sclerotherapy (CDFS).
Methods: A prospective blinded randomized clinical trial comparing
the occlusion rates of GSV at 1-, 6-, and 12-month follow-up. Fifty pa-
tients were included and randomized into two groups. CDFS was per-
formed accessing the GSV at knee level and applying 8 mL of 2%
polidocanol-foam (EasyFoam) while the catheter was withdrawn. Strictly
perivenous TA was performed in group 1 before applying the sclerosant
agent. Occlusion rates and clinical scores were assessed by blinded
examiners.
Results: After 12 months in group 1 full occlusion was achieved in
73.9%, partial occlusion in 8.7%, and 17.4% were classiﬁed as treatment fail-
ure. In group 2, 75% of the targeted GSV were fully occluded, 20% were
partially occluded, and 5% were diagnosed as treatment failure. Both groups
showed a signiﬁcant reduction of the vein diameter. Patient's tolerance and
satisfaction with the treatment was high in both groups.
Conclusion: No beneﬁt could be found using additional TA to
reduce the vein diameter before the treatment.The Effect of Different b-Blockers on Vascular Graft Nitric Oxide
Levels: Comparison of Nebivolol Versus Metoprolol
Bayar E., Ilhan G., Furat C., Atik C., Arslanoglu Y., Kuran C., Ozpak B.,
Durakoglugil M.E. Eur J Vasc Endovasc Surg 2014;47:203-7.
Objectives: The aim of this study was to investigate the effects of the
vasodilating b-blocker nebivolol and the cardioselective b-blocker metopro-
lol on nitric oxide (NO) levels at vascular graft endothelium and vasa vaso-
rum compared to controls in patients undergoing coronary artery bypass
graft surgery.
Methods: This was a prospective study. Fifty-ﬁve patients were
divided into three groups: nebivolol group (group N, n ¼ 23), metoprolol
group (group M, n ¼ 16), and control group (group A, n ¼ 16). Group N
received nebivolol 5 mg once daily, and group M received metoprolol 50
mg once daily for 15 days in the preoperative period. Control patients did
not use b-blocker therapy. Tissue samples of both left internal mammary ar-
tery (LIMA) and saphenous vein grafts were investigated for NO activity us-
ing immunohistochemical methods.
Results: Demographic characteristics and risk factors were similar be-
tween groups. We observed the highest NO activity in group N in both
endothelial and vasa vasorum samples of LIMA and saphenous veins. NO
activity of metoprolol group was similar to controls.
Conclusions: According to our results, we think that nebivolol may
be safer and preferable in order to diminish graft spasm in patients undergo-
ing coronary artery bypass graft surgery due to the NO-mediated vasodilat-
ing effect.
